Patient reported outcome (PRO) endpoints: Optimal development, collection, analysis planning and reporting

In recent years, various guidelines have been developed to promote the optimal planning, collection, analysis and reporting of PRO endpoints in clinical trials. This presentation will introduce those resources, and provide some top tips for successfully and collaboratively planning and implementing PRO endpoints in a clinical trial.

Dr. Rebecca Mercieca-Bebber

Dr Rebecca Mercieca-Bebber is an NHMRC Early Career Fellow and the Quality of Life Lead at the NHMRC Clinical Trials Centre, the University of Sydney. Her research focuses on the methodology of patient-reported outcomes (PROs) in clinical trials and she leads the PRO endpoints of several oncology, COVID-19 and nephrology Australian and international clinical trials. She is also an executive member of the ISOQOL Best Practices for PROs Taskforce, which led the development of the SPIRIT-PRO guidelines for PRO content of trial protocols